Ciofu, Oana <br/><br/>
Antibodies against beta-lactamase can improve ceftazidime treatment of lung infection with beta-lactam-resistant Pseudomonas aeruginosa in a rat model of chronic lung infection.  [electronic resource] 

 -  APMIS : acta pathologica, microbiologica, et immunologica Scandinavica  Dec 2002 
 - 881-91 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0903-4641 
<br/><br/><label>Standard No.: </label>10.1034/j.1600-0463.2002.1101207.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies, Bacterial--biosynthesis<br/>Antibody Affinity<br/>Antibody Specificity<br/>Bacterial Proteins--immunology<br/>Biofilms<br/>Ceftazidime--therapeutic use<br/>Chronic Disease<br/>Enzyme-Linked Immunosorbent Assay<br/>Female<br/>Immunization<br/>Immunization, Secondary<br/>Immunoglobulin G--biosynthesis<br/>Microspheres<br/>Models, Animal<br/>Neutralization Tests<br/>Pneumonia, Bacterial--drug therapy<br/>Pseudomonas Infections--drug therapy<br/>Pseudomonas aeruginosa--drug effects<br/>Rats<br/>Rats, Inbred Lew<br/>beta-Lactam Resistance<br/>beta-Lactamases--immunology